Human Chorionic Gonadotrophin in an Antagonist Protocol

NCT01833858 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cairo University